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1. INTRODUCTION 
Hydrolysis of GTP at the guanine nucleotide- 
binding regulatory component (N-protein) appears 
to terminate hormone-induced adenylate cyclase 
stimulation [1,2]. Hormonal factors which stimu- 
late adenylate cyclase increase the activity of a 
high affinity GTPase, which appears to be an inte- 
grated part of the N-protein [3-5]. In several sys- 
tems, cholera toxin has been shown to inhibit this 
hormone-induced GTPase stimulation [5-7]. This 
GTPase inhibition, which appears to be due to a 
toxin-induced ADP-ribosylation of the N-protein 
[8], results in a persistent activation of the adenyl- 
ate cyclase. Hormonal factors, which inhibit aden- 
ylate cyclase, such as a-adrenergic agonists in 
human platelets [9], prostaglandins and adenosine 
receptor agonists in hamster adipocytes [10,11] and 
opiates in neuroblastoma × glioma hybrid cells 
[12], also stimulate a high affinity GTPase in mem- 
brane preparations. Here, we report hat in human 
platelet membranes cholera toxin inhibits the high 
affinity GTPase stimulation by prostaglandin E1 
(PGE1), which stimulates adenylate cyclase, 
whereas the toxin does not impair GTPase stim- 
ulation by adrenaline, which inhibits adenylate 
cyclase in this membrane system. 
2. MATERIALS AND METHODS 
Materials used were as in [13]. Human platelet 
membranes, prepared as in [13], were pretreated in
a medium containing, if not otherwise stated, 
0.1 mM ATP, 0.2 mM GTP, 5 mM MgCI2, 2 mM 
NAD, 2 mM dithiothreitol (DTT), l mM EDTA, 
5 mM creatine phosphate, 0.4 mg creatine kinase/ 
ml, 0.2% bovine serum albumin and 50 mM so- 
dium phosphate buffer (pH 7.1) or 50 mM tri- 
ethanolamine-HC1 (pH 7.4) for 10 rain at 30°C 
without and with cholera toxin at the indicated 
concentrations. The toxin was preactivated for 
10 min at 37°C with 20 mM DTT. After treatment, 
the membranes were pelleted by centrifugation 
(5 rain, 30 000 x g) and resuspended in I0 mM tri- 
ethanolamine-HCl (pH 7.4) (fig.l). In the other 
experiments shown, the membranes were washed 
twice with an excess of triethanolamine-HC1 
(10 raM, pH 7.4)/EDTA (0.1 raM) and were then 
used for enzyme assays or treatment with N-eth- 
ylmaleimide (NEM). For this treatment, he wash- 
ed platelet membranes were incubated for 30 rain 
at 0°C with NEM (5 or 10 mM) and were then 
washed with an excess of fl-mercaptoethanol, es- 
sentially as in [3,5]. After centrifugation for 10 min 
at 30000 × g, the final pellet was suspended in 
10 mM triethanolamine-HC1 (pH 7.4) for enzyme 
assays. 
Adenylate cyclase activity was determined as in 
[14] with 0.1 mM [a-32p]ATP (-0.4~Ci/tube), 2
or 30mM MgC12, 5mM creatine phosphate, 
i.2 mg creatine kinase/ml, 0.270 bovine serum al- 
bumin, 30/~M D,L-propanolol, 1 mM DTT, 
0.1 mM EDTA, 1 mM 3-isobutyl-l-methylxan- 
thine, 0.1 mM cyclic AMP and 0.3/~M GTP in 
50 mM triethanolamine-HCl (pH 7.4) in 100/~1 
total vol. Reactions were initiated by addition of 
platelet membranes (50-80 ~g protein/tube) and 
conducted for 5 min at 30°C. Cyclic AMP formed 
was isolated as in [14]. GTPase activity was deter- 
mined according to [3] with essentially the same 
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reaction mixture as used for adenylate cyclase as- 
say, with the exception that 0.3 ~M [y-32p]GTP 
(-0.2/~Ci/tube) and 0.1 mM unlabeled ATP were 
present. Reactions were started by addition of 
platelet membranes (3 -10~g protein/tube) and 
conducted for 5 or 10 min at 30°C. Determination 
of the released 32p i was performed by the charcoal 
method exactly as in [11]. 
3. RESULTS 
Pretreatment of human platelet membranes with 
cholera toxin (1-100 Fg/ml) increased basal aden- 
ylate cyclase activity measured with 2 mM MgC12 
up to -30-fold (fig.l). At 100 ~g/ml, the cholera 
toxin-induced activation was identical to that in- 
duced by PGE1 (10/~M). At this maximally effec- 
tive concentration of PGEh cholera toxin caused 
no further increase in activity. Adrenaline 
(300 ttM) decreased basal and PGEl-stimulated 
adenylate cyclase activities. After preactivation 
with cholera toxin, the adrenaline-induced inhibi- 
tion was largely increased in the absence of PGEI 
and not affected in the presence of PGEI. At 
100 p,g cholera toxin/ml, inhibitions of control and 
PGEl-stimulated activities were identical. Under 
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Fig.l. Influence of cholera toxin on human platelet 
adenylate cyclase. Human platelet membranes were pre- 
treated without and with cholera toxin at the indicated 
concentrations for 5 min at 37°C with 30 ~M GTP in the 
preactivation medium. Adenylate cyclase activity was 
determined with 2 mM MgC12 in the absence (o) and 
presence of PGE] (D, 10 ~M), adrenaline (., 300 ~M) or 
PGE] plus adrenaline (=). 
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Fig.2. Influence of cholera toxin on human platelet 
membrane GTPase. Human platelet membranes were 
pretreated without and with cholera toxin at the indi- 
cated concentrations, and after the washing procedure 
with NEM (10 mM), as in section 2. GTPase activity was 
determined in the absence (.) and presence of adrena- 
line (D, 300 ~M) or PGEt (o, 10 t.tM). Incubation was for 
5 min in the presence of 30 mM MgCI2. Means +__ SEM 
are given. 
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Table 1 
Influence of cholera toxin on adrenaline-induced increase in GTPase ac- 
tivity in human platelet membranes 
Additions Control Cholera toxin 
(pmol GTP hydrolyzed, mg protein-t, min-I) 
None 75.4 _ 2.2 70.8 ±. 1.1 
Adrenaline (100/tM) 103 ±3.0 (36) 96.1 ± 1.5 (35) 
Human platelet membranes were treated without and with cholera toxin 
(200/~g/ml). GTPase activity was determined in the presence of 2 mM 
MgCl2 without and with adrenaline (100/~M). Means _+ SEM are given• 
Numbers in parentheses indicate % stimulation 
September 1982 
these conditions, which were optimal for demon- 
stration of adrenaline-induced a enylate cyclase 
inhibition, the influence of cholera toxin on adren- 
aline-induced GTPase stimulation was studied. In 
the absence of cholera toxin, adrenaline (100/~M) 
increased GTP hydrolysis -35% (table l). Treat- 
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ment of platelet membranes with cholera toxin 
(200/tg/ml) had absolutely no effect on GTPase 
stimulation by the ~-adrenergic agonist. The small 
decrease in basal GTPase activity was not ob- 
served in other experiments. 
Stimulation of GTP hydrolysis in human plate- 
let membranes by PGEI was very small under 
these conditions and was hampered by the high 
background basal GTPase activity [5]. In order to 
study the effect of cholera toxin on PGEi-induced 
GTPase stimulation, human platelet membranes 
were treated with the SH reagent, NEM, which has 
been shown to decrease basal but not PGEl-stimu- 
lated GTP hydrolysis [3,5]. Pretreatment of platelet 
membranes with 10mM NEM (30min, 0°C) 
markedly decreased basal GTP hydrolysis ( -5 -  
fold). Under this condition, cholera toxin con- 
centration-dependently reduced stimulation of the 
GTPase by PGEI (fig.2). In the absence of the 
toxin, PGEI (10/~M) increased GTPase activity by 
10 pmol. mg - !  . min - l  (80% stimulation)• 
After treatment with 20 ~g cholera toxin/ml, the 
Fig.3. Influence of cholera toxin on GTPase stimulation 
by PGEI, adrenaline and their combination. Platelet 
membranes were pretreated without and with cholera 
toxin (100~g/ml) and with NEM (5 mM) as in fig.2. 
GTPase activity was determined in the presence of fol- 
lowing additions; (l) none; (2) adrenaline (100/tM); (3) 
PGEI (l ~tM); (4) adrenaline plus PGEt; (5) adrenaline 
+ PGEI + phentolamine (50 ~M). Incubation was for 
l0 min in the presence of 30 mM MgCl2. 
Means _ SEM are given. 
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stimulatory effect of PGEI was reduced to 
3 pmol • mg I.  min 1 (20% stimulation). Simi- 
lar data were reported in [5]. In the NEM-pre- 
treated membranes, GTPase stimulation by adren- 
aline was very small [13]. But this small stimulation 
was not affected by cholera toxin, even at the high- 
est concentration used. 
In human platelet membranes, timulations of 
GTP hydrolysis by PGEI and adrenaline are 
largely additive, and only the adrenaline-induced 
stimulation is blocked by the c~-adrenoceptor an- 
tagonist, phentolamine [9]. Similar data were ob- 
tained after treatment with cholera toxin (fig.3). 
Cholera toxin (100/~g/ml) largely reduced GTPase 
stimulation induced by PGEI (1/~M), whereas the 
small stimulation by adrenaline (100/2M) was not 
impaired but rather increased. In the presence of 
both hormonal factors, the stimulations were addi- 
tive, and phentolamine (50 t~M) specifically antag- 
onized the adrenaline-induced GTPase activation. 
4. DISCUSSION 
In human platelet membranes, adrenaline via 
a2-adrenoceptors inhibits adenylate cyclase and 
stimulates a high affinity GTPase [9]. In the same 
membrane system PGEI, which stimulates adenyl- 
ate cyclase, also increases GTP hydrolysis by a 
high affinity GTPase [5,9]. These data demonstrate 
that treatment of platelet membranes with cholera 
toxin enlarges adrenaline-induced adenylate 
cyclase inhibition [15] and does not attenuate 
GTPase stimulation by this a-adrenergic agonist. 
In contrast, cholera toxin markedly inhibited 
GTPase stimulation by PGEI, as reported in [5]. 
These findings suggest hat two functionally dis- 
tinct GTPase enzymes are involved in adenylate 
cyclase regulation. One GTPase is activated by 
hormones that stimulate adenylate cyclase and ap- 
pears to terminate the hormone-induced a enylate 
cyclase stimulation; this GTPase, which appears to 
be an integrated part of the stimulatory coupling 
protein, is inhibited by cholera toxin [1,2]. The 
other GTPase is stimulated by hormones that in- 
hibit adenylate cyclase and appears to be closely 
related to this inhibitory process, possibly causing 
also termination of the hormone action; this 
GTPase is apparently not affected by cholera 
toxin. In hamster adipocyte membranes stimula- 
tion of a high affinity GTPase by an adenylate 
cyclase inhibitory hormone was not attenuated by 
cholera toxin [16]. This finding supports the view 
that two functionally distinct GTPases are in- 
volved in adenylate cyclase regulation by stimula- 
tory and inhibitory hormones. 
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